• Stock Chart

    Stock Chart

    GW Pharmaceuticals Plc(GWPH)

    NASDAQ

    $125.35

    -0.84(-0.666%)

    GWPH Company Profile

    Sovereign House
    Vision Park, Chivers Way Histon
    Cambridge, Cambridgeshire CB24
    44.1223.266800
    http://gwpharm.co.uk
    Sector: Health Technology
    Industry: Pharmaceuticals: Other
    Full Time Employees: 901

    GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.

    • Previous Close
      126.19
    • Open
      127.5
    • Bid
    • Ask
    • Day's Range
      124.26 - 127.765
    • 52 week Range
      67.98 - 180.75
    • Volume
      271061
    • Avg. Volume
      308039
    • Market Cap
      3891166971
    • Beta (5Y Monthly)
      127.5
    • PE Ratio (TTM)
      119.32
    • EPS (TTM)
    • Earnings Date
      127.5
    • Forward Dividend & Yield
      127.5
    • Ex-Dividend Date
      271061
    • 1y Target Est
      127.5

    KEEP ME INFORMED ON GWPH UPDATES

    GWPH Performance

    • 5 Day
      4.2845%
    • 1 Month
      -2.5045%
    • 3 Month
      53.2396%
    • YTD
      20.9709%
    • 1 Year
      -28.6852%

    GWPH on iHub

    GWPH News

    /*
  • */